Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway.
暂无分享,去创建一个
[1] K. Nan,et al. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. , 2005, World journal of gastroenterology.
[2] S. Fan,et al. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. , 2005, Carcinogenesis.
[3] G. Nicolson,et al. Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. , 2005, The American journal of pathology.
[4] S. Fan,et al. FTY720 Attenuates Hepatic Ischemia‐Reperfusion Injury in Normal and Cirrhotic Livers , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] S. Fan,et al. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. , 2004, Carcinogenesis.
[6] M. Matsuda,et al. Decreased expression of CD28 coincides with the down‐modulation of CD3ζ and augmentation of caspase‐3 activity in T cells from hepatocellular carcinoma‐bearing patients and hepatitis C virus‐infected patients , 2004, Journal of gastroenterology and hepatology.
[7] T. Fujii,et al. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. , 2004, Journal of hepatology.
[8] Y. Maehara,et al. Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma , 2004, Clinical Cancer Research.
[9] S. Fan,et al. Liver transplantation for hepatocellular carcinoma , 2004, The British journal of surgery.
[10] S. Horie,et al. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. , 2003, The Journal of urology.
[11] M. Ikekita,et al. A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells , 2003, British journal of pharmacology.
[12] N. Forones,et al. Apoptosis, PCNA and p53 in hepatocellular carcinoma. , 2002, Hepato-gastroenterology.
[13] N. Nonomura,et al. Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: Modulation of mitogenic signaling, FAK, cell‐cycle entry and apoptosis , 2002, International journal of cancer.
[14] N. Ichimaru,et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. , 2002, Cancer research.
[15] D. Yamamoto,et al. FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells. , 2001, Biochemical and biophysical research communications.
[16] M. Iacocca,et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] S. Enosawa,et al. Evidence that FTY720 induces T cell apoptosis in vivo. , 2000, Immunopharmacology.
[18] J. Wong,et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. , 2000, Annals of surgery.
[19] M. Kogire,et al. Effect of a New Immunosuppressive Agent, Fty720, on Survival of Islet Allografts , 1998, Cell transplantation.
[20] J. Bruix,et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution , 1998, Hepatology.
[21] S. Kawai,et al. A New Immunosuppressant, FTY720, Prolongs Limb Allograft Survival in Rats , 1998, Annals of plastic surgery.
[22] S. Enosawa,et al. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. , 1996, Immunopharmacology.
[23] S. Enosawa,et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. , 1996, Transplantation.
[24] W. Cance,et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.
[25] W. Cance,et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer , 2006, Annals of Surgical Oncology.
[26] A. Cör,et al. Proliferative and apoptotic activity in hepatocellular carcinoma and surrounding non-neoplastic liver tissue , 2001, Pflügers Archiv.